Spotlight
Clinical
Events
CME
Partners
Subscribe
- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
Researchers identify molecular target for diabetic retinopathy
Boston-Activation of vascular endothelial growth factor (VEGF) may initiate blood-retinal barrier breakdown during the onset of diabetes in rats. The VEGF activity seems to occur partly in the capillaries and venules of the superficial layer of the retina.
Related Videos
Related Content
